Geneva, June 16 -- International Clinical Trials Registry received information related to the study (ACTRN12625000573459) titled 'Effect of delta-9-tetrahydrocannbinol (THC) on obstructive sleep apnoea and the mechanisms which cause it' on June 3.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Crossover
Type of endpoint: Efficacy
Primary Sponsor: Centre for Sleep Science, University of Western Australia
Condition:
obstructive sleep apnoea
obstructive sleep apnoea
Respiratory - Sleep apnoea
Intervention:
Oral delta-9-tetrahydrocannabinol (THC) 10mg gel capsule/night, approximately 1 hour prior to bedtime. Taken on a single night at lea...